Finance

Lists
Why is RCEL up ६.०९%?
Dive Deeper
RCEL:NASDAQ
AVITA Medical Inc
US$ १३.९४
+६.०९%
(+०.८०) 1D
अक्टोबर २०, १४:३७:३७ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RCEL...
Open
US$ १३.२९
High
US$ १४.०८
Low
US$ १३.२९
Mkt. cap
४३.०८ करोड
Avg. vol.
३.२२ लाख
Volume
२.२५ लाख
52-wk high
US$ १४.०८
52-wk low
US$ ३.२२
EPS
-US$ १.४४
Beta
१.९९
Shares outstanding
३.०९ करोड
No. of employees
२२६
Open
US$ १३.२९
High
US$ १४.०८
Low
US$ १३.२९
Mkt. cap
४३.०८ करोड
Avg. vol.
३.२२ लाख
Volume
२.२५ लाख
52-wk high
US$ १४.०८
52-wk low
US$ ३.२२
EPS
-US$ १.४४
Beta
१.९९
Shares outstanding
३.०९ करोड
No. of employees
२२६
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
११ मिनेट पहिले
Did Board Appointment Just Shift Amplitude (AMPL) Investment Narrative?
Yahoo Finance
Yahoo Finance
·
१९ मिनेट पहिले
Ed Yardeni spots a major shakeup in the S&P 500
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees२२६
Founded१९९९
HeadquartersValencia, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 3 analysts giving stock ratings to RCEL in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for RCEL in the last 3 months.
Highest
Current US$ १३.९४
US$ १५.०० (+७.६०%)
Average
US$ १३.६७ (-१.९४%)
Lowest
US$ १२.०० (-१३.९२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Buy
Maintained
US$ १५.००
+७.६%
10/12/2026
Josh Jennings
TD Cowen
Buy
Maintained
US$ १४.००
+०.४%
09/17/2026
Frank Takkinen
Lake Street
Buy
Reiterated
US$ १२.००
-१३.९%
08/28/2026
Chad Messer
Lake Street
Buy
Reiterated
US$ ६.००
-५७%
07/16/2026
Carl Byrnes
Northland Securities
Buy
Maintained
US$ १०.००
-२८.३%
03/26/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.७१ करोड
१.७६ करोड
१.९३ करोड
२.१७ करोड
Cost of goods sold
३१.८७ लाख
३३.०४ लाख
३५.२३ लाख
३९.३५ लाख
Cost of revenue
३१.८७ लाख
३३.०४ लाख
३५.२३ लाख
३९.३५ लाख
Research and development expenses
३७.४८ लाख
५६.९१ लाख
५६.२९ लाख
५०.७८ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९३ करोड
१.९० करोड
१.८९ करोड
१.९५ करोड
Operating expense
२.३० करोड
२.४७ करोड
२.४५ करोड
२.४६ करोड
Total operating expenses
२.६२ करोड
२.८० करोड
२.८१ करोड
२.८६ करोड
Operating income
-९१.५३ लाख
-१.०४ करोड
-८८.०३ लाख
-६८.५५ लाख
Other non operating income
४९.०० हजार
७.३७ लाख
-९५.०० हजार
-१२.०० हजार
EBT including unusual items
-१.३२ करोड
-१.१६ करोड
-१.०६ करोड
-७६.३० लाख
EBT excluding unusual items
-१.२३ करोड
-१.१० करोड
-१.०३ करोड
-७८.३० लाख
Income tax expense
१५.०० हजार
-१७.०० हजार
-११.०० हजार
३३.०० हजार
Effective tax rate
-०.११%
०.१५%
०.१०%
-०.४३%
Other operating expenses
-
-
-
-
Net income
-१.३२ करोड
-१.१६ करोड
-१.०६ करोड
-७६.६३ लाख
Net profit margin
-७७.२९%
-६५.९७%
-५५.१२%
-३५.३१%
Earnings per share
-
-
-
-
Interest and investment income
३.०० लाख
२.०० लाख
-
५.०० लाख
Interest expense
-३४.६८ लाख
-१५.५० लाख
-१४.२४ लाख
-१४.६३ लाख
Net interest expenses
-३१.६८ लाख
-१३.५० लाख
-१४.२४ लाख
-९.६३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८५.७९ लाख
-९७.६१ लाख
-८१.७६ लाख
-६२.५० लाख
Gain or loss from assets sale
२.५२ लाख
५.०० हजार
५५.०० हजार
१.८८ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू